This course introduces you to Health Technology Assessment (HTA) as a concept (what it is, what it involves) and then takes you through the key stages in the HTA and decision-making process:
Identifying technologies for development;
Evaluating these technologies in trials and measuring key outcomes, such as Quality of Life (health economics)
Appraising and pooling the evidence from these trials to determine the effect of a technology (clinical effectiveness review)
Assessing the cost-effectiveness of those technologies (decision-analytic modelling)
Considering how the results from this HTA process are used to inform reimbursement and pricing decisions in different countries
This course necessarily only offers a simple and brief introduction to, and overview of each of these stages in the process. However, it uses materials adapted from the online, distance learning full postgraduate programme on International HTA, Pricing and Reimbursement.